Financhill
Sell
43

RGCO Quote, Financials, Valuation and Earnings

Last price:
$20.31
Seasonality move :
2.26%
Day range:
$19.54 - $20.43
52-week range:
$17.90 - $24.20
Dividend yield:
3.94%
P/E ratio:
17.50x
P/S ratio:
2.44x
P/B ratio:
1.93x
Volume:
62.8K
Avg. volume:
12.8K
1-year change:
-4.87%
Market cap:
$208.3M
Revenue:
$84.6M
EPS (TTM):
$1.16
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $63.1M $75.2M $84.2M $97.4M $84.6M
Revenue Growth (YoY) -7.28% 19.18% 11.96% 15.77% -13.14%
 
Cost of Revenues $40.5M $49.7M $58M $67.7M $54.3M
Gross Profit $22.6M $25.5M $26.2M $29.8M $30.3M
Gross Profit Margin 35.84% 33.91% 31.07% 30.55% 35.79%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $5.5M $2.6M -$53.6M $2.7M $4.9M
Operating Expenses $10.1M $10.7M $11.2M $12.1M $13.2M
Operating Income $12.5M $14.8M $14.9M $17.7M $17.1M
 
Net Interest Expenses $4.1M $4.1M $4.5M $5.6M $6.5M
EBT. Incl. Unusual Items $13.9M $13.3M -$43.1M $14.8M $15.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.3M $3.2M -$11.4M $3.5M $3.7M
Net Income to Company $10.6M $10.1M -$31.7M $11.3M $11.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10.6M $10.1M -$31.7M $11.3M $11.8M
 
Basic EPS (Cont. Ops) $1.30 $1.22 -$3.48 $1.14 $1.16
Diluted EPS (Cont. Ops) $1.30 $1.22 -$3.48 $1.14 $1.16
Weighted Average Basic Share $8.1M $8.3M $9.1M $9.9M $10.2M
Weighted Average Diluted Share $8.1M $8.3M $9.1M $9.9M $10.2M
 
EBITDA $26.1M $26M -$29.5M $30.4M $32.5M
EBIT $18M $17.4M -$38.6M $20.4M $22M
 
Revenue (Reported) $63.1M $75.2M $84.2M $97.4M $84.6M
Operating Income (Reported) $12.5M $14.8M $14.9M $17.7M $17.1M
Operating Income (Adjusted) $18M $17.4M -$38.6M $20.4M $22M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $9.8M $13.4M $14.1M $12.5M $13.1M
Revenue Growth (YoY) -0.73% 36.55% 5.67% -11.66% 5.11%
 
Cost of Revenues $8.2M $10.3M $11M $8.7M $9.7M
Gross Profit $1.6M $3.1M $3.1M $3.8M $3.4M
Gross Profit Margin 15.98% 23.17% 21.97% 30.15% 25.91%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $1.4M $345.2K -$14.7M $2M $1.8M
Operating Expenses $2.5M $2.5M $2.6M $3M $3.2M
Operating Income -$899.1K $555.2K $454.7K $744.1K $242.4K
 
Net Interest Expenses $989.5K $1M $1.2M $1.4M $1.7M
EBT. Incl. Unusual Items -$453.7K -$123.7K -$15.4M $1.3M $267.4K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$124.4K -$124.2K -$4M $304.5K $126.6K
Net Income to Company -$329.3K $480 -$11.4M $1M $140.8K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$329.3K $480 -$11.4M $1M $140.8K
 
Basic EPS (Cont. Ops) -$0.04 $0.00 -$1.16 $0.10 $0.01
Diluted EPS (Cont. Ops) -$0.04 $0.00 -$1.16 $0.10 $0.01
Weighted Average Basic Share $8.2M $8.4M $9.8M $10M $10.2M
Weighted Average Diluted Share $8.2M $8.4M $9.8M $10M $10.2M
 
EBITDA $2.5M $3M -$12M $5.3M $4.4M
EBIT $535.8K $900.4K -$14.2M $2.7M $2M
 
Revenue (Reported) $9.8M $13.4M $14.1M $12.5M $13.1M
Operating Income (Reported) -$899.1K $555.2K $454.7K $744.1K $242.4K
Operating Income (Adjusted) $535.8K $900.4K -$14.2M $2.7M $2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $63.1M $75.2M $84.2M $97.4M $84.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $40.5M $49.7M $58M $67.7M $54.3M
Gross Profit $22.6M $25.5M $26.2M $29.8M $30.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $5.5M $2.6M -$53.6M $2.7M $4.9M
Operating Expenses $10.1M $10.7M $11.2M $12.1M $13.2M
Operating Income $12.5M $14.8M $14.9M $17.7M $17.1M
 
Net Interest Expenses $4.1M $4.1M $4.5M $5.6M $6.5M
EBT. Incl. Unusual Items $13.9M $13.3M -$43.1M $14.8M $15.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.3M $3.2M -$11.4M $3.5M $3.7M
Net Income to Company $10.6M $10.1M -$31.7M $11.3M $11.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10.6M $10.1M -$31.7M $11.3M $11.8M
 
Basic EPS (Cont. Ops) $1.31 $1.23 -$3.56 $1.14 $1.16
Diluted EPS (Cont. Ops) $1.30 $1.23 -$3.56 $1.14 $1.16
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $26.1M $26M -$29.5M $30.4M $32.7M
EBIT $18M $17.4M -$38.6M $20.4M $22M
 
Revenue (Reported) $63.1M $75.2M $84.2M $97.4M $84.6M
Operating Income (Reported) $12.5M $14.8M $14.9M $17.7M $17.1M
Operating Income (Adjusted) $18M $17.4M -$38.6M $20.4M $22M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $75.2M $84.2M $97.4M $84.6M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $49.7M $58M $67.7M $54.3M --
Gross Profit $25.5M $26.2M $29.8M $30.3M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $2.6M -$53.6M $2.7M $4.9M --
Operating Expenses $10.7M $11.2M $12.1M $13.2M --
Operating Income $14.8M $14.9M $17.7M $17.1M --
 
Net Interest Expenses $4.1M $4.5M $5.6M $6.5M --
EBT. Incl. Unusual Items $13.3M -$43.1M $14.8M $15.5M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.2M -$11.4M $3.5M $3.7M --
Net Income to Company $10.1M -$31.7M $11.3M $11.8M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10.1M -$31.7M $11.3M $11.8M --
 
Basic EPS (Cont. Ops) $1.23 -$3.56 $1.14 $1.16 --
Diluted EPS (Cont. Ops) $1.23 -$3.56 $1.14 $1.16 --
Weighted Average Basic Share $33M $36.5M $39.7M $40.6M --
Weighted Average Diluted Share $33.1M $36.5M $39.7M $40.6M --
 
EBITDA $26M -$29.5M $30.4M $32.7M --
EBIT $17.4M -$38.6M $20.4M $22M --
 
Revenue (Reported) $75.2M $84.2M $97.4M $84.6M --
Operating Income (Reported) $14.8M $14.9M $17.7M $17.1M --
Operating Income (Adjusted) $17.4M -$38.6M $20.4M $22M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $291.1K $1.5M $4.9M $1.5M $894.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.4M $4.9M $5.4M $4.2M $4.5M
Inventory $6.7M $8.9M $18.1M $12.9M $10.3M
Prepaid Expenses $647.6K $3.1M $3.1M $3.2M $2.4M
Other Current Assets $3.4M $6.7M $2.8M $3.5M $6.2M
Total Current Assets $14.4M $25.1M $35.5M $26.8M $25.1M
 
Property Plant And Equipment $198.4M $211.6M $229.9M $247.6M $262M
Long-Term Investments $57.5M $64.9M $13.8M $17.2M $21.1M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $285K $418.9K $293.6K $624.1K $703.4K
Total Assets $281.7M $310.1M $290.3M $303.7M $320.7M
 
Accounts Payable $4.4M $7.7M $8.6M $5.8M $5.4M
Accrued Expenses $3.6M $3.8M $3.7M $4.7M $5M
Current Portion Of Long-Term Debt -- $7M $1.3M $11M $800K
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.4M $662.4K $3.2M $1.7M $860K
Total Current Liabilities $16.6M $26M $22.3M $32.9M $28.7M
 
Long-Term Debt $123.8M $133.5M $135.7M $125.8M $136.7M
Capital Leases -- -- -- -- --
Total Liabilities $192.8M $210.4M $197.2M $203M $212.6M
 
Common Stock $40.8M $41.9M $49.1M $50.1M $51.2M
Other Common Equity Adj -$3.4M -$1.5M $2M $2.3M $1.3M
Common Equity $88.9M $99.7M $93.1M $100.7M $108.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $88.9M $99.7M $93.1M $100.7M $108.1M
 
Total Liabilities and Equity $281.7M $310.1M $290.3M $303.7M $320.7M
Cash and Short Terms $291.1K $1.5M $4.9M $1.5M $894.2K
Total Debt $123.8M $140.5M $137M $141.2M $148.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $291.1K $1.5M $4.9M $1.5M $894.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.4M $4.9M $5.4M $4.2M $4.5M
Inventory $6.7M $8.9M $18.1M $12.9M $10.3M
Prepaid Expenses $647.6K $3.1M $3.1M $3.2M $2.4M
Other Current Assets $3.4M $6.7M $2.8M $3.5M $6.2M
Total Current Assets $14.4M $25.1M $35.5M $26.8M $25.1M
 
Property Plant And Equipment $198.4M $211.6M $229.9M $247.6M $262M
Long-Term Investments $57.5M $64.9M $13.8M $17.2M $21.1M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $285K $418.9K $293.6K $624.1K $703.4K
Total Assets $281.7M $310.1M $290.3M $303.7M $320.7M
 
Accounts Payable $4.4M $7.7M $8.6M $5.8M $5.4M
Accrued Expenses $3.6M $3.8M $3.7M $4.7M $5M
Current Portion Of Long-Term Debt -- $7M $1.3M $11M $800K
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.4M $662.4K $3.2M $1.7M $860K
Total Current Liabilities $16.6M $26M $22.3M $32.9M $28.7M
 
Long-Term Debt $123.8M $133.5M $135.7M $125.8M $136.7M
Capital Leases -- -- -- -- --
Total Liabilities $192.8M $210.4M $197.2M $203M $212.6M
 
Common Stock $40.8M $41.9M $49.1M $50.1M $51.2M
Other Common Equity Adj -$3.4M -$1.5M $2M $2.3M $1.3M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $88.9M $99.7M $93.1M $100.7M $108.1M
 
Total Liabilities and Equity $281.7M $310.1M $290.3M $303.7M $320.7M
Cash and Short Terms $291.1K $1.5M $4.9M $1.5M $894.2K
Total Debt $123.8M $140.5M $137M $141.2M $148.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $10.6M $10.1M -$31.7M $11.3M $11.8M
Depreciation & Amoritzation $8.1M $8.7M $9.2M $10M $10.5M
Stock-Based Compensation $81.4K $11.1K $16.3K $21.6K $711.9K
Change in Accounts Receivable $53.2K -$1.1M -$646.4K $1.4M -$275.2K
Change in Inventories $734.2K -$2.2M -$9.2M $5.3M $2.6M
Cash From Operations $12.8M $11.6M $15.6M $23.8M $17.4M
 
Capital Expenditures $22.9M $20M $25.5M $25.3M $22.1M
Cash Acquisitions -$7.9M -$6M -$5.3M -$2.1M -$18.3K
Cash From Investing -$30.7M -$25.8M -$30.6M -$27.4M -$22M
 
Dividends Paid (Ex Special Dividend) -$5.6M -$6M -$7M -$7.8M -$8.1M
Special Dividend Paid
Long-Term Debt Issued $43.8M $55.2M $76.2M $34.3M $56.2M
Long-Term Debt Repaid -$23.4M -$38.6M -$79.6M -$30.1M -$48.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$70.8K -$21.6K -$58.2K -$33.7K -$101.2K
Cash From Financing $16.6M $15.5M $18.4M $218.9K $4M
 
Beginning Cash (CF) $1.6M $291.1K $1.5M $4.9M $1.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.3M $1.2M $3.4M -$3.4M -$618.3K
Ending Cash (CF) $291.1K $1.5M $4.9M $1.5M $894.2K
 
Levered Free Cash Flow -$10.1M -$8.4M -$9.9M -$1.5M -$4.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$329.3K $480 -$11.4M $1M $140.8K
Depreciation & Amoritzation $2M $2.1M $2.2M $2.6M $2.2M
Stock-Based Compensation $40.7K $8.3K $10.8K -- $660.4K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$2.2K -$2.8M -$4.2M $162.4K $377.4K
 
Capital Expenditures $5.9M $5M $8M $5.9M $5.5M
Cash Acquisitions -$1.3M -$1.9M -$915.2K -$860 -$9.5K
Cash From Investing -$7.2M -$6.8M -$8.9M -$5.9M -$5.5M
 
Dividends Paid (Ex Special Dividend) -$1.4M -$1.5M -$1.9M -$2M -$2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $11.4M $15.1M $8.4M $6.2M $11.5M
Long-Term Debt Repaid -$4M -$4.8M -$2.6M -$2.4M -$7.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$6.5K -$23K -$1.8K
Cash From Financing $6.3M $9.9M $4.2M $2.1M $3.5M
 
Beginning Cash (CF) $1.2M $1.3M $13.8M $5.2M $2.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$910.1K $249.9K -$8.9M -$3.7M -$1.6M
Ending Cash (CF) $291.1K $1.5M $4.9M $1.5M $894.2K
 
Levered Free Cash Flow -$5.9M -$7.9M -$12.3M -$5.8M -$5.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $10.6M $10.1M -$31.7M $11.3M $11.8M
Depreciation & Amoritzation $8.1M $8.7M $9.2M $10M $10.5M
Stock-Based Compensation $81.4K $11.1K $16.3K $21.6K $711.9K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $12.8M $11.6M $15.6M $23.8M $17.4M
 
Capital Expenditures $22.9M $20M $25.5M $25.3M $22.1M
Cash Acquisitions -$7.9M -$6M -$5.3M -$2.1M -$18.3K
Cash From Investing -$30.7M -$25.8M -$30.6M -$27.4M -$22M
 
Dividends Paid (Ex Special Dividend) -$5.6M -$6M -$7M -$7.8M -$8.1M
Special Dividend Paid
Long-Term Debt Issued $43.8M $55.2M $76.2M $34.3M $56.2M
Long-Term Debt Repaid -$23.4M -$38.6M -$79.6M -$30.1M -$48.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$70.8K -- -$58.2K -- --
Cash From Financing $16.6M $15.5M $18.4M $218.9K $4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.3M $1.2M $3.4M -$3.4M -$618.2K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$10.1M -$8.4M -$9.9M -$1.5M -$4.7M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $10.1M -$31.7M $11.3M $11.8M --
Depreciation & Amoritzation $8.7M $9.2M $10M $10.5M --
Stock-Based Compensation $11.1K $16.3K $21.6K $711.9K --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $11.6M $15.6M $23.8M $17.4M --
 
Capital Expenditures $20M $25.5M $25.3M $22.1M --
Cash Acquisitions -$6M -$5.3M -$2.1M -$18.3K --
Cash From Investing -$25.8M -$30.6M -$27.4M -$22M --
 
Dividends Paid (Ex Special Dividend) -$6M -$7M -$7.8M -$8.1M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $55.2M $76.2M $34.3M $56.2M --
Long-Term Debt Repaid -$38.6M -$79.6M -$30.1M -$48.8M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$58.2K -$33.7K -$101.2K --
Cash From Financing $15.5M $18.4M $218.9K $4M --
 
Beginning Cash (CF) $3M $26.5M $19.9M $8.9M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2M $3.4M -$3.4M -$618.2K --
Ending Cash (CF) $4.2M $29.9M $16.6M $8.3M --
 
Levered Free Cash Flow -$8.4M -$9.9M -$1.5M -$4.7M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 7.8% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 11.48% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock